This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimada, T. Articles by Guengerich, F. P. Search for Related Content PubMed PubMed Citation Articles by Shimada, T. Articles by Guengerich, F. P.

Roles of Individual Human Cytochrome P-450 Enzymes in the Bioactivation of Benzo(a)pyrene, 7,8-Dihydroxy-7,8-dihydrobenzo(a)pyrene, and Other Dihydrodiol Derivatives of Polycyclic Aromatic Hydrocarbons¹

Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 [T. S., M. V. M., F. P. G.], and Department of Chemistry, Wayne State University, Detroit, Michigan 48202 [D. P-S., L. J. M.]

Human liver microsomes oxidized 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene [B(a)P-7,8-diol] to products that yield DNA adduct formation and umu gene expression in the tester system Salmonella typhimurium TA1535/pSK1002. The umu response is correlated to levels of microsomal cytochrome P-450_NF (P-450_NF) and nifedipine oxidation in different human liver samples used for activation, and both the (+)- and (-)-enantiomers of B(a)P-7,8-diol gave similar results in these and other assays. The microsomal umu response was inhibited by antibodies raised against P-450_NF. 7,8-Benzoflavone stimulated the B(a)P-7,8-diol-dependent umu response observed with purified P-450_NF and human liver and lung microsomes. Thus, P-450_NF appears to be the major enzyme involved in the activation of B(a)P-7,8-diol in human liver and possibly lung. Similar results were obtained for the activation of trans-9,10-dihydroxy-9,10-dihydrobenzo(b)fluoranthene and trans-3,4-dihydroxy-3,4-dihydro-7,12-dimethylbenz(a)anthracene, compounds that are known to form highly tumorigenic diol-epoxides. The major product of the oxidation of (+)-B(a)P-7,8-diol was the cis-syn isomer of benzo(a)pyrene-7,8,9,10-tetraol[7ß,8,9ß,10ß-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene]. Studies on the nature of the human liver enzymes involved in the formation of B(a)P-7,8-diol [from benzo(a)pyrene] indicate that neither P-450_NF, P-450_PA, P-450_J, P-450_DB, nor P-450_MP is involved. The correlation of 7,8-diol formation with phenacetin O-deethylation in a set of liver samples and the partial inhibition of the reaction by 7,8-benzoflavone and anti-rat P-450_ßNF-B suggest that the enzyme involved may be P₁-450, the human ortholog of rat P-450_ßNF-B, which catalyzes both the formation of B(a)P-7,8-diol and its subsequent oxidation in tissues of polycyclic hydrocarbon-treated rats. The differential effects of inhibitors indicate that benzo(a)pyrene 3-hydroxylation, 4,5-epoxidation, and 9,10-epoxidation are catalyzed by an enzyme(s) distinct from that which forms the 7,8-epoxide. The roles of the human P-450 enzymes differ from the rodent orthologs in the paradigm for bioactivation of polycyclic hydrocarbons; further, flavones appear to have opposing effects on diol formation and further epoxidation in both human liver and lung.

¹ Supported in part by USPHS Grants CA 44353 and ES 00267 (F. P. G.) and CA 47479 (L. J. M.).

² Present address: Osaka Prefectural Institute of Public Health, Nakamichi, Higashinari-ku, Osaka 537, Japan.

³ Burroughs-Wellcome Scholar in Toxicology (1983–1988). To whom requests for reprints should be addressed.

Received 3/14/89. Revised 8/ 1/89. Accepted 8/17/89.

This article has been cited by other articles:

				W. Zhang, B. Moorthy, M. Chen, K. Muthiah, R. Coffee, A. F. Purchio, and D. B. West A Cyp1a2-Luciferase Transgenic CD-1 Mouse Model: Responses to Aryl Hydrocarbons Similar to the Humanized AhR Mice Toxicol. Sci., November 1, 2004; 82(1): 297 - 307. [Abstract] [Full Text] [PDF]

				S. Anttila, J. Hakkola, P. Tuominen, E. Elovaara, K. Husgafvel-Pursiainen, A. Karjalainen, A. Hirvonen, and T. Nurminen Methylation of Cytochrome P4501A1 Promoter in the Lung Is Associated with Tobacco Smoking Cancer Res., December 15, 2003; 63(24): 8623 - 8628. [Abstract] [Full Text] [PDF]

				S. Chen, N. Nguyen, K. Tamura, M. Karin, and R. H. Tukey The Role of the Ah Receptor and p38 in Benzo[a]pyrene-7,8-dihydrodiol and Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced Apoptosis J. Biol. Chem., May 23, 2003; 278(21): 19526 - 19533. [Abstract] [Full Text] [PDF]

				J. Hukkanen, T. Vaisanen, A. Lassila, R. Piipari, S. Anttila, O. Pelkonen, H. Raunio, and J. Hakkola Regulation of CYP3A5 by Glucocorticoids and Cigarette Smoke in Human Lung-Derived Cells J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 745 - 752. [Abstract] [Full Text] [PDF]

				T. Shimada, K. Inoue, Y. Suzuki, T. Kawai, E. Azuma, T. Nakajima, M. Shindo, K. Kurose, A. Sugie, Y. Yamagishi, et al. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice Carcinogenesis, July 1, 2002; 23(7): 1199 - 1207. [Abstract] [Full Text] [PDF]

				T. Shimada, Y. Oda, E. M. J. Gillam, F. P. Guengerich, and K. Inoue Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Other Procarcinogens by Cytochromes P450 1A1 and P450 1B1 Allelic Variants and Other Human Cytochromes P450 in Salmonella typhimurium NM2009 Drug Metab. Dispos., September 1, 2001; 29(9): 1176 - 1182. [Abstract] [Full Text] [PDF]

				A. A. Nomeir, C. Ruegg, M. Shoemaker, L. V. Favreau, J. R. Palamanda, P. Silber, and C.-c. Lin Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates Drug Metab. Dispos., April 13, 2001; 29(5): 748 - 753. [Abstract] [Full Text]

				W. L. Casley, J. A. Menzies, L. W. Whitehouse, and T. W. Moon Detection of Quantitative Trait Loci Affecting Caffeine Metabolism by Interval Mapping in a Genome-Wide Scan of C3H/HeJ x APN F2 Mice Drug Metab. Dispos., December 1, 1999; 27(12): 1375 - 1380. [Abstract] [Full Text]

				A. Luch, S. Kishiyama, A. Seidel, J. Doehmer, H. Greim, and W. M. Baird The K-Region trans-8,9-Diol Does Not Significantly Contribute as an Intermediate in the Metabolic Activation of Dibenzo[a,l]pyrene to DNA-binding Metabolites by Human Cytochrome P450 1A1 or 1B1 Cancer Res., September 1, 1999; 59(18): 4603 - 4609. [Abstract] [Full Text] [PDF]

				S. Ozawa, B. Schoket, L.P. McDaniel, Y.-M. Tang, C. B. Ambrosone, S. Kostic, I. Vincze, and F. F. Kadlubar Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases Carcinogenesis, June 1, 1999; 20(6): 991 - 995. [Abstract] [Full Text] [PDF]

				R. A. Brooks, N. J. Gooderham, R. J. Edwards, A. R. Boobis, and D. J. Winton The mutagenicity of benzo[a]pyrene in mouse small intestine Carcinogenesis, January 1, 1999; 20(1): 109 - 114. [Abstract] [Full Text] [PDF]

				J. M. Machinist, M. D. Mayer, E. M. Roberts, B. W. Surber, and A. D. Rodrigues Identification of the Human Liver Cytochrome P450 Enzymes Involved in the In Vitro Metabolism of a Novel 5-Lipoxygenase Inhibitor Drug Metab. Dispos., October 1, 1998; 26(10): 970 - 976. [Abstract] [Full Text]

				W. R. Fields, C. S. Morrow, A. J. Doss, K. Sundberg, B. Jernström, and A. J. Townsend Overexpression of Stably Transfected Human Glutathione S-Transferase P1-1 Protects against DNA Damage by Benzo[a]pyrene Diol-Epoxide in Human T47D Cells Mol. Pharmacol., August 1, 1998; 54(2): 298 - 304. [Abstract] [Full Text]

				Y.-T. Hou, H.-K. Lin, and T. M. Penning Dexamethasone Regulation of the Rat 3alpha -Hydroxysteroid/Dihydrodiol Dehydrogenase Gene Mol. Pharmacol., March 1, 1998; 53(3): 459 - 466. [Abstract] [Full Text]

				D. J. Fraser, R. Feyereisen, G. R. Harlow, and J. R. Halpert Isolation, Heterologous Expression and Functional Characterization of a Novel Cytochrome P450 3A Enzyme from a Canine Liver cDNA Library J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1425 - 1432. [Abstract] [Full Text]

				J. C. Willey, E. L. Coy, M. W. Frampton, A. Torres, M. J. Apostolakos, G. Hoehn, W. H. Schuermann, W. G. Thilly, D. E. Olson, J. R. Hammersley, et al. Quantitative RT-PCR Measurement of Cytochromes p450 1A1, 1B1, and 2B7, Microsomal Epoxide Hydrolase, and NADPH Oxidoreductase Expression in Lung Cells of Smokers and Nonsmokers Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 114 - 124. [Abstract] [Full Text]

				A. P. Koley, J. T.M. Buters, R. C. Robinson, A. Markowitz, and F. K. Friedman Differential Mechanisms of Cytochrome P450 Inhibition and Activation by alpha -Naphthoflavone J. Biol. Chem., February 7, 1997; 272(6): 3149 - 3152. [Abstract] [Full Text] [PDF]

				M. E. Staretz, S. E. Murphy, C. J. Patten, M. G. Nunes, W. Koehl, S. Amin, L. A. Koenig, F. P. Guengerich, and S. S. Hecht Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'-Nitrosonornicotine in Human Hepatic Microsomes Drug Metab. Dispos., February 1, 1997; 25(2): 154 - 162. [Abstract] [Full Text]